Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > Lux buying ISA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by teeveeon Aug 07, 2010 11:26pm
429 Views
Post# 17331254

RE: Lux buying ISA

RE: Lux buying ISAIf Lux's deal survives an ISA bankruptcy, Lux wouldn't have to buy ISA. Paladin can manufacture the drug for any additional trials. Who knows, maybe Lux could get out of paying any milestone payments too? If Lux's deal doesn't survive an ISA bankruptcy, then I would offer say $.8/share on a share exchange ratio, which might be on the order of 1 Lux share for each 1000 ISA shares-take it or leave it. $.08/share or zero? which would you accept?   
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities